✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹143 Cr.
P/E
12.41

Key Ratios

Market cap
Market cap
143 Cr
PE
PE
12.41
Prom Holding
Prom Holding
72.30 %
ROE (%)
ROE (%)
13.43
ROCE (%)
ROCE (%)
16.27
Div Yield (%)
Div Yield (%)
-
Sales
Sales
187 Cr
OPM (%)
OPM (%)
14.26 %
Debt to Equity
Debt to Equity
0.99
About
Parnax Lab Limited (formerly Krishna Deep Trade & Investment Limited) is principally engaged i… Read more
Low
81
52W Range
High
194
  • Parnax Lab
  • Murae Organisor
  • Mangalam Drugs&Org.

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Parnax Lab Ltd. Business

Parnax Lab Limited manufactures and exports pharmaceutical formulations. They have manufacturing facilities in sectors such as pharmaceuticals, cosmetics, herbal medicine, and nutraceuticals. The company operates in Silvassa and Baddi, Himachal Pradesh.

Parnax Lab major competitors are Murae Organisor, Mangalam Drugs&Org., Tyche Inds, Sotac Pharmaceutical, Denis Chem Lab, Smruthi Organics, Bal Pharma.
Market Cap of Parnax Lab is ₹143 Crs.
While the median market cap of its peers are ₹140 Crs.

Parnax Lab seems to be less financially stable compared to its competitors.
Altman Z score of Parnax Lab is 2.4 and is ranked 5 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material